Immune Checkpoint Inhibitors in Cardiac Sarcoma: Reason to Take Heart?
JACC CardioOncol
.
2024 Feb 20;6(1):80-82.
doi: 10.1016/j.jaccao.2024.01.002.
eCollection 2024 Feb.
Author
Mark S Diamond
1
Affiliation
1
Division of Hematology Oncology, University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania, USA.
PMID:
38510298
PMCID:
PMC10950427
DOI:
10.1016/j.jaccao.2024.01.002
No abstract available
Keywords:
cardiac tumors; immunotherapy; outcomes; sarcoma.
Publication types
Editorial